Anlotinib Alone or in Combination With Temozolomide in the Treatment of Recurrent High-Grade Glioma: A Retrospective Analysis

• Asıl Yazarlar: Qunying Yang (Yazar), Chengcheng Guo (Yazar), Xiaoping Lin (Yazar), Lili Luo (Yazar), Zhenqiang He (Yazar), Fuhua Lin (Yazar), Ji Zhang (Yazar), Yinsheng Chen (Yazar), Xiaobing Jiang (Yazar), Chao Ke (Yazar), Yonggao Mou (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Frontiers Media S.A., 2021-12-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Background: Anlotinib is a multi-target anti-angiogenic agent. This retrospective study aimed to evaluate the efficacy and safety of anlotinib alone or in combination with temozolomide for the treatment of recurrent high-grade glioma.Materials and Methods: The clinical data of patients with recurren...